In vitro experiments showed that when IL-2 was used to stimulate B cells in SLE, it was found that although the proliferation of B cells was weakened, the ability of IL-2 to up-regulate PD-L1 was also decreased. The gene discussed is CD274; the disease is systemic lupus erythematosus.